Fayaz Master

Fayaz Master has extensive experience in clinical operations, currently serving as Director of Clinical Operations at BioNTech SE since November 2024. Previously, Fayaz held various leadership roles at Scancell Ltd, including Director of Clinical Operations and Head of Clinical Operations, from November 2021 to November 2024. Prior to that, Fayaz was Head of Clinical Development at Allergy Therapeutics and held senior positions at ClinMed Pharma and BTG plc, where responsibilities included overseeing clinical development initiatives. Fayaz began a career in clinical research at Bayer and Cancer Research UK, contributing to multiple phases of clinical trials. Fayaz holds a Bachelor of Science degree in Medicinal and Pharmaceutical Chemistry from Queen Mary University of London, completed in 2003.